China Medical System’s Innovative Oral Drug for Vitiligo, Povorcitinib Enrolls First Patient in China Phase III Clinical Trial

SHENZHEN, CHINA – China Medical System Holdings Limited (“CMS” or the “Group”, 867.HK/8A8.SG) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in …

China Medical System’s Innovative Oral Drug for Vitiligo, Povorcitinib Enrolls First Patient in China Phase III Clinical Trial Read More

neoseek Builds on a Decade of Engineering Expertise to Accelerate Global Expansion in Portable Charging

Building on established engineering capabilities, international design recognition, and product innovation, neoseek is expanding its global reach with portable charging solutions. Hong Kong, China, 19th Nov 2026 – neoseek, an …

neoseek Builds on a Decade of Engineering Expertise to Accelerate Global Expansion in Portable Charging Read More